Cullinan Oncology LLC (CGEM) — Cash Flow Quality Index
Cullinan Oncology LLC (CGEM) has a Cash Flow Quality Index of -0.15x as of June 2022. Operating cash flow of $-25.42 Million is below net income of $174.90 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CGEM cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cullinan Oncology LLC Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for Cullinan Oncology LLC across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CGEM cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Cullinan Oncology LLC (2022–2022)
Year-by-year earnings quality comparison for Cullinan Oncology LLC. For live market cap and the full company financial profile, see Cullinan Oncology LLC (CGEM) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -1.16x | $-126.66 Million | $109.19 Million | — |